Peculiarities of the daily profile of arterial pressure and its impact on the outcomes of patients with chronic kidneys disease, receiving program hemodialysis


DOI: https://dx.doi.org/10.18565/therapy.2019.2.19-23

Vyalkina N.A., Klyashev S.M., Vyalkina Y.A., Mezhonov E.M., Klyasheva Y.M.

FSBEI HE «Tyumen State Medical University» of the Ministry of Healthcare of Russia
The purpose of the study is to assess the prognostic value of daily blood pressure (BP) profile on outcomes in patients with end-stage chronic kidney disease (ESKD). Material and methods. Examined 100 patients with ESKD. During the annual prospective study found the relationship of mortality and the combined endpoint of the severity of hypertension, assess the circadian rhythm of BP. In all patients showed predominance of the «non-dipper» type and the increase rate of rise of the morning BP of the patients studied which indicates a high risk of adverse events. Results. Revealed an increase in mortality with increasing levels of daytime and nighttime diastolic BP, nighttime systolic BP. It found a direct relationship between the violation of circadian BP profile, insufficient correction of hypertension and incidence of endpoints. Conclusion. Violation of the circadian rhythm of BP combined with a lack of correction of hypertension has an adverse prognostic value in patients on hemodialysis.

Literature



  1. Anna Clementi, Grazia Maria Virzì, Ching Yan Goh, Dinna N. Cruz, Antonio Granata, Girogio Vescovo and Claudio Roncob. Cardiorenal syndrome type 4: a review. Cardiorenal. Med. 2013; 3(1): 63–70.

  2. Kotanko P., Garg A.X., Depner T. et al. Effects of frequent hemodialysis on blood pressure: results from the randomized frequent hemodialysis network trials. Hemodial Int. 2015; 19(3): 386–401.

  3. Springera J., Villa-Forte A. Thrombosis in vasculitis. Curr. Opin. Rheumatol. 2013; 25: 19–25.

  4. Zoccali C., Tripepi R., Torino C. et al. Moderator’s view: Ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients. Nephrol. Dial. Transplant. 2015; 30(9): 1443–48.

  5. Quiroz Y., Johnson R.J., Rodriguez-Iturbe B. The role of T cells in the pathogenesis of primary hypertension. Nephrol. Dial. Transplant. 2012; 27(4): 2–5.

  6. Masson P., Webster A.C., Hong M. et al. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol. Dial. Transplant. 2015; 30: 1162–69.

  7. Mohammad Reza Khosoosi Niaki, Mehrdad Saravi, Farshid Oliaee, Roghayeh Akbari, Sepideh Noorkhomami, Seyed Hassan Bozorgi Rad, Kobra Fallahpoor, Mir Saeed Ramezani Changes in QT interval before and after hemodialysis. Caspian J. Intern. Med. 2013; 4(1): 590–94.

  8. Bonati L.H., Dobson J., Featherstone R.L. et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015; 385: 529–38.

  9. McIntyre C.W., Goldsmith D.J. Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? Kidney Int. 2015; 87: 1109–15.

  10. Milovanova L., Milovanov Y., Plotnikova A. Phosphorus and calcium metabolism disorders assosiated with chronic kidney disease stage III-IV: systematic review and meta-analysis. chronic. Kidney Disease and renal. Transplantation. 2012: 95–118.

  11. Maino A., Rossio R. et al. Hypereosinophilic syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr. Vasc. Pharmacol. 2012; 10: 670–75.

  12. Вялкина Н.А., Кляшев С.М., Межонов Е.М., Вялкина Ю.А. Прогностическое значение артериальной гипертонии и хронической сердечной недостаточности у больных с терминальной стадией ХПН, получающих программный гемодиализ. Медицинская наука и образование Урала. 2014; 2: 56–59.

  13. Qamar A., Bhatt D.L. Anticoagulation therapy: balancing the risks of stroke and bleeding in CKD. Nat. Rev. Nephrol. 2015; 11: 200–02.

  14. Kron S., Schneditz D., Leimbach T. et al. Determination of the critical absolute blood volume for intradialytic morbid events. Hemodial. Int. 2016; 20(2): 321–26.

  15. Unal A., Duran M., Tasdemir K. Does arterio-venous fistula creation affects development of pulmonary hypertension in hemodialysis patients? Ren. Fail. 2013; 35(3): 344–51.

  16. Makki N., Swaminathan P.D., Hanmer J., Olshansky B. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies. Europace. 2014; 16(1): 55–62.


About the Autors


Natalia A. Vyalkina, nephrologist of Hospital №3 in Tobolsk. Address: 626150, Tobolsk, 24, 3b Str. Tel. +73456252489. E-mail: ob3@med-to.ru
Sergey M. Klyashev, MD, professor, head of the Department of therapy with the courses of endocrinology, functional and ultrasonic diagnostics of Tyumen State Medical University. Adress: 625023, Tyumen, 54, Odesskaya Str. Tel. +73452202197. E-mail: tgmu@tyumsmu.ru
Yu.A. Vyalkina, PhD, cardiologist of Tyumen City Hospital 1. Address: 625023, Tyumen, 10, Y. Semovskich Str. Tel. +73452560010. Email: okb@tokb.ru
E.M. Mezhonov, PhD, cardiologist of Tyumen City hospital 1. Address: 625023, Tyumen, 10, Y.Semovskich Str. Tel. +73452560010. Email: okb@tokb.ru
Yu.M. Klyasheva, MD, professor of the Department of therapy with the courses of endocrinology, functional and ultrasonic diagnostics Tyumen State Medical University. Address: 625023, Tyumen, 54, Odesskaya Str. Tel. +73452202197. E-mail: tgmu@tyumsmu.ru


Similar Articles


Бионика Медиа